FDA brings lab tests under federal oversight in bid to improve accuracy and safety
WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles
Philippines blames China for loss of giant clams in disputed shoal and urges environmental inquiry
MANILA, Philippines (AP) — The Philippines blamed Chinese fishermen on Monday for a massive loss of2024-05-21Kylie Kelce celebrates her sixth wedding anniversary with husband Jason
Kylie Kelce is celebrating her sixth wedding anniversary with her husband, Jason, as she also shared2024-05-21- Ariana Grande's beloved 'Nonna' - 98-year-old grandmother Marjorie Grande - has made history as the2024-05-21
CERAWeek kicks off, focusing on global multidimensional energy transition
HOUSTON, March 18 (Xinhua) -- CERAWeek, known as a superbowl forum in the global energy industry, ki2024-05-21Burglar hurled stolen mobile phones at police from the top of 60ft high roof during nine
A burglar hurled stolen mobile phones at police officers from the top of a roof during a nine-hour s2024-05-21Former world champion runner Jeruto faces doping case hearing in June ahead of Paris Olympics
LAUSANNE, Switzerland (AP) — Former steeplechase world champion Norah Jeruto faces a doping case hea2024-05-21
atest comment